ABBOTT INDIA LIMITED Fair Value
ABBOTINDIA · Healthcare · Current price ₹28,055
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹4,084 | 33% ROE fading to 12% over ~10 yrs, on ₹2247 book |
| Relative P/E | ₹23,444 | EPS × 35.2 peer-median P/E |
| Graham floor | ₹5,801 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is ABBOTT INDIA LIMITED undervalued?
DocStoX estimates the fair value of ABBOTT INDIA LIMITED at ₹9,797 per share, versus the current market price of ₹28,055. That puts the stock about -65.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹4,084), Relative P/E (₹23,444), Graham floor (₹5,801). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹4,084 (bear) to ₹9,797 (base) to ₹23,444 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on ABBOTT INDIA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.